Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Tildacerfont: 12-week extension study data presented in patients with CAH

March 23, 2021

SOV-2012-F1, oral testosterone formulation that improves patient satisfaction scores

March 23, 2021

Encouraging preliminary phase I data for RP-L301 in pyruvate kinase deficiency

March 23, 2021

AZP-3601 shows promising preliminary data in healthy male subjects

March 22, 2021

Enrollment opens in first-in-human study of mRNA-3927 for propionic acidemia

March 22, 2021

Dual labeling study finds no evidence of pancreatic beta cell neogenesis

March 19, 2021

High blood fats, sugars alter antigen processing

March 18, 2021

VX-880 enters phase I/II trial for type 1 diabetes

March 12, 2021

Hinova Pharmaceuticals identifies new thyroid hormone receptor beta agonists

March 12, 2021

Dr Reddy's Institute of Life Sciences patents 5-HT2C receptor PAAMs

March 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.